GlassScriptPhysician profile
Munir Ahmed
NPI 1639267875
$1,570.59
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,161 · 2020: $114 · 2021: $77.42 · 2022: $177 · 2023: $40.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $40.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $40.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $1,128.12 | 2019-2022 | |
| Providence Medical Technology, INC. | $85.24 | 2022 | |
| Horizon Therapeutics Plc | $65.47 | 2020-2022 | |
| Radius Health, INC. | $51.83 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $40.62 | 2023 | Uptravi, Opsumit |
| Stryker Corporation | $39.72 | 2019-2022 | |
| Boston Scientific Corporation | $36.08 | 2020 | |
| Skeletal Dynamics INC | $30.00 | 2019 | |
| Baxter Healthcare | $27.22 | 2022 | |
| Depuy Synthes Sales INC. | $16.66 | 2021 | |
| Zimmer Biomet Holdings, INC. | $13.99 | 2020 | |
| Cook Medical LLC | $13.73 | 2019 | |
| Ferring Pharmaceuticals INC. | $12.92 | 2021 | |
| Heraeus Medical, LLC. | $8.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Munir Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.